NCT07887893
Extracorporeal Shock Wave Therapy in the Treatment of Periarticular Bone Marrow Edema in Patients With Knee Osteoarthritis
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (2)
Arms and interventions
Radial extracorporeal shock wave therapy (ESWT) will be administered once weekly for 5 consecutive weeks using a BTL-6000 SWT TOPLINE shock wave therapy device. Each treatment session will consist of 2,000 shock waves delivered at a frequency of 6-8 hertz (Hz) and a pressure of 1.8-2.5 bar. Treatment will be applied directly to the skin over the predetermined bone marrow edema (BME) area identified by magnetic resonance imaging (MRI). Participants will also receive standard conservative treatment throughout the study period (13 weeks).
Sham radial extracorporeal shock wave therapy (ESWT) will be administered once weekly for 5 consecutive weeks using the same BTL-6000 SWT TOPLINE device. The device will be operated at a low setting sufficient to reproduce the characteristic treatment sound without delivering therapeutically effective shock waves. The ESWT probe will be held close to, but without direct contact with, the skin over the predetermined bone marrow edema (BME) area identified by magnetic resonance imaging (MRI). At the same time, an inactive ultrasound probe similar in size to the ESWT probe will be applied directly to the skin over the treatment area to reproduce the physical sensation of active treatment. During each session, participants will wear an eye mask, and both researchers will be present in the treatment room to maintain standardized treatment conditions and participant blinding. All participants will receive the same standard conservative treatment as the active ESWT group.
Devices: Radial Extracorporeal Shock Wave Therapy, Sham Radial Extracorporeal Shock Wave Therapy
Sites
1 site in 1 country
- Dokuz Eylul UniversityIzmir, Balcova, Turkey (Türkiye)